Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Parkinson’s disease and related disorders

Prevalence of Parkinson's disease across North America.

C Marras; J C Beck; J H Bower; E Roberts; B Ritz; G W Ross; R D Abbott; R Savica; S K Van Den Eeden; A W Willis; C M Tanner; Parkinson’s Foundation P4 Group

Originally published in NPJ Parkinson's disease · 2018-07-10

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Estimates of the prevalence of Parkinson's disease in North America have varied widely and many estimates are based on small numbers of cases and from small regional subpopulations. We sought to estimate the prevalence of Parkinson's disease in North America by combining data from a multi-study sampling strategy in diverse geographic regions and/or data sources. Five separate cohort studies in California (2), Minnesota (1), Hawaii USA (1), and Ontario, Canada (1) estimated the prevalence of PD from health-care records (3), active ascertainment through facilities, large group, and neurology practices (1), and longitudinal follow-up of a population cohort (1). US Medicare program data provided complementary estimates for the corresponding regions.

Results

The populations studied (aged ≥45 years) ranged in size from 8006 (Honolulu-Asia Aging Study (HAAS)) to 5,525,787 (Ontario). The number of cases identified by project ranged from 207 to 28,065. Table 1 shows the case numbers, denominators, and prevalence estimates for each project by sex. The supplementary table provides prevalence further broken down by age group. Figure 1 displays the prevalence estimates closest to 2010 for each project and provides the meta-analytic estimate for each age group by sex.

Discussion

Our multi-study, multi-regional approach provides current estimates for PD prevalence among individuals over the age of 45 years, which overall is 572/100,000. The estimates from the individual studies are generally similar, and the meta-estimate confidence intervals are narrow, reflecting the large size of the component studies. Despite the overall similarity, there is evidence for heterogeneity, particularly a lower estimated prevalence from the HAAS study conducted on Japanese American men in Hawaii.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?